Derivation and Validation of Charlson, Elixhauser and RxRisk Cost-Based Comorbidity Indices: A Register-Based Study of 350,000 Individuals Over 11 Years

Camilla Nystrand, Naimi Johansson, Johannes Blom

Open source

DOI
10.1007/s40273-026-01652-x
Published
2026-09-22
Container
PharmacoEconomics
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40273-026-01652-x,
  title = {Derivation and Validation of Charlson, Elixhauser and RxRisk Cost-Based Comorbidity Indices: A Register-Based Study of 350,000 Individuals Over 11 Years},
  author = {Camilla Nystrand and Naimi Johansson and Johannes Blom},
  year = {2026},
  journal = {PharmacoEconomics},
  doi = {10.1007/s40273-026-01652-x},
  url = {https://doi.org/10.1007/s40273-026-01652-x}
}

RIS

TY  - JOUR
TI  - Derivation and Validation of Charlson, Elixhauser and RxRisk Cost-Based Comorbidity Indices: A Register-Based Study of 350,000 Individuals Over 11 Years
AU  - Camilla Nystrand
AU  - Naimi Johansson
AU  - Johannes Blom
PY  - 2026
JO  - PharmacoEconomics
DO  - 10.1007/s40273-026-01652-x
UR  - https://doi.org/10.1007/s40273-026-01652-x
ER  - 

APA

Nystrand, C., Johansson, N., & Blom, J. (2026). Derivation and Validation of Charlson, Elixhauser and RxRisk Cost-Based Comorbidity Indices: A Register-Based Study of 350,000 Individuals Over 11 Years. PharmacoEconomics. https://doi.org/10.1007/s40273-026-01652-x

Source records